New findings out of the University of Tübingen show that, on top of its benefits for metabolism, mood, and general health, exercise also improves brain function. In recent studies, researchers learned that obese and overweight ...
Jul 10, 2019
0
0
(HealthDay) -- A widely prescribed drug, metformin, may lower the risk of invasive breast cancer in postmenopausal women with diabetes, a new study indicates.
Jun 11, 2012
0
0
Type 2 diabetes patients have access to an assortment of digital health tools, including mobile apps for iPhones and remote patient monitoring devices, all of which help them manage their blood glycemic levels. They can test ...
Jan 22, 2024
0
16
(HealthDay) —Patients with diabetes who have longstanding diabetes, poor glycemic control, and use insulin had suboptimal improvements in clinical outcomes after lumbar spine surgery, according to research published March ...
Apr 2, 2013
0
0
(HealthDay)—After induction short-term intensive insulin therapy (IIT), metformin is superior to intermittent IIT for maintaining beta-cell function and glycemic control over two years, according to a study published online ...
Feb 15, 2018
0
1
New research from UC shows that poor metabolic health parameters are linked to low breast milk production. The study was published in the journal Breastfeeding Medicine.
Sep 29, 2022
0
1
Hemoglobin A1c (HbA1c) level plays an important role in type 2 diabetes (T2D) treatment, serving as an important indicator of an individual's glucose control. The Endocrine Society has outlined specific HbA1c target ranges ...
Jan 19, 2024
0
6
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
Mar 17, 2023
0
2
People living with type 1 diabetes (T1D), in which the pancreas produces little or no insulin, must use replacement insulin injections to manage their blood sugar, and this insulin therapy itself increases the risk of weight ...
Oct 1, 2021
0
4
(HealthDay)—There was no effect of intensive versus conventional insulin therapy during the Diabetes Control and Complications Trial (DCCT) on cardiac parameters as assessed by cardiac magnetic resonance (CMR) in the Epidemiology ...
Apr 12, 2013
0
0
